Guardant Health: Look For Explosive Revenue Growth Ahead
2026-01-26 09:31:41 ET
Guardant Health, Inc. ( GH ) was founded in 2012 and is based in Palo Alto, CA. It describes itself as a "precision oncology company focused on guarding wellness and giving every person more time free from cancer." The company operates in the field of oncology and offers advanced blood screening and blood/tissue tests to assess biomarkers of cancer in patients. Their products/services help to improve patient outcomes through screening and monitoring alongside assistance with treatment selection, using a large database of cancer mutations to determine patient-tailored therapies. Its current market cap is just under $15 billion....
Read the full article on Seeking Alpha
For further details see:
Guardant Health: Look For Explosive Revenue Growth AheadNASDAQ: ROCH
ROCH Trading
12.23% G/L:
$28.90 Last:
2,033,245 Volume:
$25.95 Open:



